Search
forResearch 10 of 129
- Efalizumab-induced hypertrichosis
- Newly emerging type B insulin resistance (TBIR) during treatment with eculizumab for AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD): fatal outcome
- ECULIZUMAB IN THE MANAGEMENT OF CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME WITH MULTIORGAN INVOLVEMENT: A CASE REPORT
- New Drugs: Eculizumab
- Systemic treatments for alopecia areata: A systematic review
- Novel therapies for alopecia areata: The era of rational drug development
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Immune Cell-Targeting Biologics for Alopecia Areata: A New Paradigm in Precision Medicine
- Does Complement Have a Role in the Pathogenesis of Alopecia Areata?
- Reporting on Adverse Clinical Events
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →